Yi-Ran Cai

发表

ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors

Kai Zhang, B. Han, Bing Li, 2022, BMC Medicine.

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression

D. Su, Xiaoqing Shi, Yi-Ran Cai, 2019, BMC Cancer.

Heterogeneous components of lung adenocarcinomas confer distinct EGFR mutation and PD-L1 expression

D. Su, Yi-Ran Cai, Minghuan Yang, 2020 .

Well-differentiated fetal adenocarcinoma of the lung: clinicopathologic features of 45 cases in China.

Baolan Li, Qunhui Wang, Hong-Mei Zhang, 2018, International journal of clinical and experimental pathology.

Clonality and allelotype analyses of focal nodular hyperplasia compared with hepatocellular adenoma and carcinoma.

Q. Su, Zhi‐hua Liu, L. Gong, 2009, World journal of gastroenterology.

X-chromosomal inactivation analysis of uterine leiomyomas reveals a common clonal origin of different tumor nodules in some multiple leiomyomas.

Q. Su, Wei Zhang, X. Diao, 2007, International journal of oncology.

Expression of MET and SOX2 genes in non-small cell lung carcinoma with EGFR mutation.

Jianxin Ye, Yan Liu, Hong-Hong Yan, 2011, Oncology reports.

Detection of MET and SOX2 amplification by quantitative real-time PCR in non-small cell lung carcinoma.

Zi-hui Li, Yi-Ran Cai, J. Mu, 2011, Oncology letters.

Expression level of CRKL and AXL combined with exon 19 deletion in EGFR and ALK status confer differential prognosis of lung adenocarcinoma subtypes.

D. Su, Yi-Ran Cai, Yujie Dong, 2016, Oncology letters.

Differential expression of CRKL and AXL genes in lung adenocarcinoma subtypes according to the epidermal growth factor receptor and anaplastic lymphoma kinase gene status.

Da-ping Yu, D. Su, Dan Zhao, 2014, Biomedical reports.

[Pathologic diagnosis of endometrial carcinoma in curettage specimens in women under forty years of age].

Mei-qing Wang, Yi-Ran Cai, Qing-hui Zhang, 2005, Zhonghua bing li xue za zhi = Chinese journal of pathology.

Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas

D. Su, Yi-Ran Cai, Yujie Dong, 2016, Scientific Reports.

Association between the histological subtype of lung adenocarcinoma, EGFR/KRAS mutation status and the ALK rearrangement according to the novel IASLC/ATS/ERS classification.

D. Su, Yi-Ran Cai, J. Mu, 2016, Oncology letters.

Effective Codelivery of lncRNA and pDNA by Pullulan‐Based Nanovectors for Promising Therapy of Hepatocellular Carcinoma

T. Xia, Ruibin Li, Yi-Ran Cai, 2016 .